BioStem Technologies share price logo

BioStem Technologies

NASDAQ: BSEM

$4.04

-0.36

(-8.07%)

as on

BioStem Technologies Stock Performance

as on September 23, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $4.02
    $4.46
    downward going graph

    0.50%

    Downside

    10.40%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

BioStem Technologies share price movements today

Previous Close
$4.40
Open
$4.38
Volume
513.5K
Market Cap
$84.5M
Day's Low - High
$4.02 - $4.46

BioStem Technologies Historical Returns

1 Month Return
+ 24.29 %
3 Month Return
+ 13.06 %
1 Year Return
-12.7 %
3 Year Return
+ 69.23 %
5 Year Return
0 %

BioStem Technologies Stock Fundamentals & Key Indicators

Check BioStem Technologies market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$84.5M

EPS (TTM)

-1.6646

Dividend Yield

0.00%

PE Ratio (TTM)

-2.85

Industry PE ratio

-2.33

PEG Ratio

0.03362255704497722

Return On Equity TTM

-76.13%

BioStem Technologies Stock Valuation

Track how BioStem Technologies P/E has moved over time to understand its valuation trends.

BioStem Technologies in the last 5 years

  • Overview

  • Trends

Lowest (-9.77x)

December 31, 2025

Today (-9.77x)

December 31, 2025

Industry (-2.33x)

December 31, 2025

Highest (7.11x)

March 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -9.77x

BioStem Technologies vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of BioStem Technologies with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BioStem Technologies image
BioStem Technologies
Buy$84.5MNA-2.85113.91%0.00%
Moderna image
Moderna
Neutral$61.5B-60.76%-19.3-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$128.8B177.16%29.3586.04%0.00%
Regeneron image
Regeneron
Buy$80.8B23.35%18.4884.86%0.47%

Stock Returns calculator for BioStem Technologies Stock including INR - Dollar returns

The BioStem Technologies stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

BioStem Technologies investment value today

Current value as on today

₹86,765

Returns

-₹13,235

(-13.24%)

Returns from BioStem Technologies Stock

-₹19,841 (-19.84%)

Dollar Impact

₹6,606 (+6.61%)

Analyst Recommendation on BioStem Technologies Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for BioStem Technologies. Average target price of $7

Indian Investors' Interest in BioStem Technologies Stock

Search interest for BioStem Technologies Stock has increased by 157% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:157% versus previous 30 day period

BioStem Technologies Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
3
41
74
82
72
49
10
-84
6
7
Gross Profit
3
39
70
78
71
48
9
-85
3
4
Operating Income
0
4
8
9
5
0
1
-7
-8
-8
EBITDA
0
4
8
9
5
0
1
-7
-8
-7
Interest Expense
0
0
0
0
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
0
4
8
9
5
0
1
-7
-8
-8
Income Tax Expense
-
1
2
2
0
0
0
3
-
-
Net Income
0
3
6
6
4
0
0
-11
-8
-8
Net Profit Margin
91.46%
94.56%
94.90%
94.87%
98.82%
98.61%
87.95%
100.54%
52.47%
52.55%

BioStem Technologies Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Dec 2025
Total Revenue
0
1
2
2
4
6
16
301
47
Gross Profit
0
0
1
1
2
5
15
288
44
Operating Income
-4
-7
-5
-1
-1
-4
-7
31
0
EBITDA
-4
-7
-5
-1
0
-6
-7
31
0
Interest Expense
0
0
0
0
0
0
0
0
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-4
-7
-6
-2
-1
-7
-8
30
0
Income Tax Expense
0
-
0
-
-
-
-
-1
6
Net Income
-4
-7
-6
-2
-1
-7
-8
31
-6
Net Profit Margin
54.44%
40.82%
49.83%
49.64%
66.03%
87.17%
92.44%
95.37%
93.13%

BioStem Technologies Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-1
3
6
6
3
0
0
-11
-8
-8
Operating Cash Flow
0
0
6
9
4
5
-2
2
0
-5
Investing Cash Flow
0
0
0
-1
0
0
-1
0
-15
0
Financing Cash Flow
0
0
0
0
0
0
0
0
-
-1
Change in Cash
0
0
5
8
3
4
-3
2
-15
-6

BioStem Technologies Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Dec 2025
Net Income
-4
-7
-6
-2
-1
-7
-8
31
-6
Operating Cash Flow
-1
-3
0
0
0
0
-3
24
9
Investing Cash Flow
0
0
0
0
0
0
0
-1
-2
Financing Cash Flow
1
5
0
0
0
0
3
0
-1
Change in Cash
0
1
-1
0
0
0
0
22
6

BioStem Technologies News & Key Events

  • img

    Today's Timeline - 18 September

    Sat, 02:26 AM

    -

    BioStem secures a $40 million equity financing facility, allowing opportunistic capital raising over 36 months.

    Sat, 03:00 AM

    -

    BioStem Technologies files to sell 12.05M shares of common stock by selling stockholders; company receives no proceeds.

Insights on BioStem Technologies

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, BSEM stock has moved up by 9.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 73.0% return, outperforming this stock by 3.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 551.1% return, outperforming this stock by 563.8%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 761.05K → -8.97M (in $), with an average decrease of 1278.8% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 4 quarters, 102.87M → 7.89M (in $), with an average decrease of 39.5% per quarter

About BioStem Technologies

BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje OPTIC, a structural tissue allograft used as a protective covering during the repair of ocular surfaces; American Amnion AC, a human connective tissue matrix for homologous use; and American Amnion, a human connective tissue matrix for homologous use. The company was formerly known as Caribbean International Holdings Inc. and changed its name to BioStem Technologies, Inc. in August 2014. BioStem Technologies, Inc. was incorporated in 2006 and is based in Fort Lauderdale, Florida.
OrganisationBioStem Technologies
Headquarters4901 Northwest 17th Way, Fort Lauderdale, FL, 33309, US
IndustryBiotechnology
CEOJason Matuszewski
E-voting on sharesClick here to vote

Key Management of BioStem Technologies

Name

Title

Mr. Noah Agron

Vice President of Corporate Finance & Strategy

Ms. Katherine Gorrell

Chief Legal & Compliance Officer

Dr. David M. Woynarowski

Chief Medical Officer

Mr. Larry Jones

Chief Revenue Officer

Mr. Brandon Poe

Chief Financial Officer

Mr. Michael A. Fortunato CPA

Chief Accounting Officer

Mr. Jeff Humke

Vice President of Human Resources

Dr. Irmgard Huber M.D.

International Medical Advisor & Interim Chief Medical Officer

Mr. Jason V. Matuszewski

CEO, President, Secretary & Chairman

Mr. Andrew Van Vurst CTBS

COO & Director

FAQs

What is BioStem Technologies share price today?

BioStem Technologies share price today is $4.04 as on at the close of the market. BioStem Technologies share today touched a day high of $4.46 and a low of $4.02.

What is the 52 week high and 52 week low for BioStem Technologies share?

BioStem Technologies share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . BioStem Technologies stock price today i.e. is closed at $4.04,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is BioStem Technologies's market capitalisation today?

BioStem Technologies market capitalisation is $0.00T as on .

How to invest in BioStem Technologies Stock (BSEM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for BioStem Technologies on INDmoney app. Click on Buy button. You can invest as low as $1.5 in BioStem Technologies Shares that will get you 0.3713 shares as per BioStem Technologies share price of $4.04 per share as on September 23, 2026 at 1:29 am IST.

What is the minimum amount required to buy BioStem Technologies Stock (BSEM) from India?

Indian investors can start investing in BioStem Technologies (BSEM) shares with as little as ₹95.58 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹955.80 in BioStem Technologies stock (as per the Rupee-Dollar exchange rate as on ). Based on BioStem Technologies share’s latest price of $4.04 as on September 23, 2026 at 1:29 am IST, you will get 2.4752 shares of BioStem Technologies. Learn more about fractional shares .